Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission

Simple item page
dc.contributor.authorPiel, Frédéric Bernard
dc.contributor.authorRees, David C.
dc.contributor.authorDeBaun, Michael R.
dc.contributor.authorNnodu, Obiageli E.
dc.contributor.authorRanque-Francois, Brigitte
dc.contributor.authorThompson, Alexis A.
dc.contributor.authorWare, Russell E.
dc.contributor.authorAbboud, Miguel Raul
dc.contributor.authorAbraham, Allistair A.
dc.contributor.authorAmbrose, Emmanuela Eusebio
dc.contributor.authorAndemariam, Biree
dc.contributor.authorColah, Roshan B.
dc.contributor.authorColombatti, Raffaella
dc.contributor.authorConran, Nicola
dc.contributor.authorCosta, Fernando Ferreira
dc.contributor.authorCronin, Robert Michael
dc.contributor.authorde Montalembert, Marianne
dc.contributor.authorElion, Jacques E.
dc.contributor.authorEsrick, Erica B.
dc.contributor.authorGreenway, Anthea L.
dc.contributor.authorIdris, Ibrahim Musa
dc.contributor.authorIssom, David Zacharie
dc.contributor.authorJain, Dipty L.
dc.contributor.authorJordan, Lori Chaffin
dc.contributor.authorKaplan, Zane S.
dc.contributor.authorKing, Allison A.
dc.contributor.authorLloyd-Puryear, Michele Ann
dc.contributor.authorOppong, Samuel A.
dc.contributor.authorSharma, Akshay
dc.contributor.authorSung, Lillian
dc.contributor.authorTshilolo, Léon Muepu
dc.contributor.authorWilkie, Diana J.
dc.contributor.authorOhene-Frempong, Kwaku O.
dc.contributor.departmentPediatrics and Adolescent Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:11:28Z
dc.date.available2025-01-24T12:11:28Z
dc.date.issued2023
dc.identifier.doihttps://doi.org/10.1016/S2352-3026(23)00096-0
dc.identifier.eid2-s2.0-85166442023
dc.identifier.pmid37451304
dc.identifier.urihttp://hdl.handle.net/10938/32566
dc.language.isoen
dc.publisherElsevier Ltd
dc.relation.ispartofThe Lancet Haematology
dc.sourceScopus
dc.subjectAnemia, sickle cell
dc.subjectGlobal health
dc.subjectHematology
dc.subjectHumans
dc.subjectAciclovir
dc.subjectAmlodipine
dc.subjectBch bb694
dc.subjectBetibeglogene autotemcel
dc.subjectCefepime
dc.subjectCeftazidime
dc.subjectCotrimoxazole
dc.subjectFilgrastim
dc.subjectFluconazole
dc.subjectGene therapy agent
dc.subjectHemoglobin gamma chain
dc.subjectHydralazine
dc.subjectHydroxyurea
dc.subjectLabetalol
dc.subjectLevetiracetam
dc.subjectMagnesium sulfate
dc.subjectUnclassified drug
dc.subjectVancomycin
dc.subjectVoxelotor
dc.subjectAfrica
dc.subjectAllogeneic hematopoietic stem cell transplantation
dc.subjectBlood cell count
dc.subjectBlood transfusion
dc.subjectBone necrosis
dc.subjectCell therapy
dc.subjectCerebrovascular disease
dc.subjectChronic pain
dc.subjectClinical evaluation
dc.subjectCognitive defect
dc.subjectComorbidity
dc.subjectCoronavirus disease 2019
dc.subjectData analysis
dc.subjectData base
dc.subjectData quality
dc.subjectData quantity
dc.subjectDemographics
dc.subjectDisease severity
dc.subjectDisease surveillance
dc.subjectEconomic cost
dc.subjectEducation program
dc.subjectEnvironmental factor
dc.subjectEnvironmental risk
dc.subjectErythrocytapheresis
dc.subjectEvidence based practice
dc.subjectGene addition therapy
dc.subjectGene editing
dc.subjectGene therapy
dc.subjectGenetic counseling
dc.subjectGenetic risk factor
dc.subjectGenetic screening
dc.subjectGenetic trait
dc.subjectGeographic mapping
dc.subjectGlobal disease burden
dc.subjectGynecologist
dc.subjectHealth care access
dc.subjectHealth care cost
dc.subjectHealth care disparity
dc.subjectHealth care financing
dc.subjectHealth care personnel
dc.subjectHealth care system
dc.subjectHigh income country
dc.subjectHuman
dc.subjectImplementation science
dc.subjectIn vivo gene transfer
dc.subjectInfection
dc.subjectKidney disease
dc.subjectLancet hematology commission
dc.subjectLeg ulcer
dc.subjectLife expectancy
dc.subjectMedical assessment
dc.subjectMedical service
dc.subjectMedical student
dc.subjectMiddle income country
dc.subjectMortality
dc.subjectNetwork analysis
dc.subjectNewborn morbidity
dc.subjectNewborn screening
dc.subjectNursing care
dc.subjectObstetrics
dc.subjectOutcome assessment
dc.subjectPandemic
dc.subjectPhase 1 clinical trial (topic)
dc.subjectPhase 2 clinical trial (topic)
dc.subjectPoint of care testing
dc.subjectPractice guideline
dc.subjectPrevalence
dc.subjectPriapism
dc.subjectProspective study
dc.subjectPsychotherapy
dc.subjectPublic health insurance
dc.subjectPulmonary hypertension
dc.subjectQuality control
dc.subjectReview
dc.subjectRisk factor
dc.subjectSickle cell anemia
dc.subjectSickle cell crisis
dc.subjectSociodemographics
dc.subjectTraining
dc.subjectVitreoretinal surgery
dc.titleDefining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2023-5482.pdf
Size:
6.28 MB
Format:
Adobe Portable Document Format
Download

Collections

Pediatrics and Adolescent Medicine